Identification of G-protein-coupled receptor 120 as a tumor-promoting receptor that induces angiogenesis and migration in human colorectal carcinoma

Oncogene

Volumn 32, Issue 49, 2013, Pages 5541-5550

  Wu, Q ^a   Wang, H ^a   Zhao, X ^a   Shi, Y ^a   Jin, M ^a   Wan, B ^a   Xu, H ^a   Cheng, Y ^a   Ge, H ^a   Zhang, Y ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

angiogenesis; colorectal carcinoma; GPR120; migration

Indexed keywords

CYCLOOXYGENASE 2; G PROTEIN COUPLED RECEPTOR 120; G PROTEIN COUPLED RECEPTOR 40; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 8; PHOSPHATIDYLINOSITOL 3 KINASE; PROSTAGLANDIN E2; PROTEIN KINASE B; TUMOR PROMOTER; UVOMORULIN; VASCULOTROPIN; VIMENTIN;

ADULT; ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARCINOMA CELL; CELL MIGRATION; CELL MOTILITY; CELL PROLIFERATION; CHEMOTAXIS; COLORECTAL CARCINOMA; CONTROLLED STUDY; CORRELATION ANALYSIS; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MAJOR CLINICAL STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TUMOR GROWTH;

ANIMALS; CADHERINS; CELL LINE, TUMOR; CELL MOVEMENT; COLORECTAL NEOPLASMS; DINOPROSTONE; ENZYME ACTIVATION; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; HUMANS; INTERLEUKIN-8; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; MIDDLE AGED; NEOPLASM TRANSPLANTATION; NEOVASCULARIZATION, PATHOLOGIC; NF-KAPPA B; PHOSPHATIDYLINOSITOL 3-KINASES; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTORS, G-PROTEIN-COUPLED; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84890548520     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2013.264     Document Type: Article

References (41)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T et al. Cancer statistics, 2008. CA Cancer J Clin 2008; 58: 71-96.
2. Taborga M, Corcoran KE, Fernandes N, Ramkissoon SH, Rameshwar P. G-coupled protein receptors and breast cancer progression: potential drug targets. Mini Rev Med Chem 2007; 7: 245-251.
3. Oh da Y, Lagakos WS. The role of G-protein-coupled receptors in mediating the effect of fatty acids on inflammation and insulin sensitivity. Curr Opin Clin Nutr Metab Care 2011; 14: 322-327.
4. Hara T, Hirasawa A, Ichimura A, Kimura I, Tsujimoto G. Free fatty acid receptors FFAR1 and GPR120 as novel therapeutic targets for metabolic disorders. J Pharm Sci 2011; 100: 3594-3601.
5. Oh da Y, Olefsky JM. Omega 3 fatty acids and GPR120. Cell Metab 2012; 15: 564-565.
6. Tanaka T, Katsuma S, Adachi T, Koshimizu TA, Hirasawa A, Tsujimoto G. Free fatty acids induce cholecystokinin secretion through GPR120. Naunyn Schmiedebergs Arch Pharmacol 2008; 377: 523-527.
7. Hirasawa A, Tsumaya K, Awaji T, Katsuma S, Adachi T, Yamada M et al. Free fatty acids regulate gut incretin glucagon-like peptide-1 secretion through GPR120. Nat Med 2005; 11: 90-94.
8. Oh DY, Talukdar S, Bae EJ, Imamura T, Morinaga H, Fan W et al. GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulinsensitizing effects. Cell 2010; 142: 687-698.
9. Ichimura A, Hirasawa A, Poulain-Godefroy O, Bonnefond A, Hara T, Yengo L et al. Dysfunction of lipid sensor GPR120 leads to obesity in both mouse and human. Nature 2012; 483: 350-354.
10. Itoh Y, Kawamata Y, Harada M, Kobayashi M, Fujii R, Fukusumi S et al. Free fatty acids regulate insulin secretion from pancreatic beta cells through GPR40. Nature 2003; 422: 173-176.
11. Briscoe CP, Peat AJ, McKeown SC, Corbett DF, Goetz AS, Littleton TR et al. Pharmacological regulation of insulin secretion in MIN6 cells through the fatty acid receptor GPR40: identification of agonist and antagonist small molecules. Br J Pharmacol 2006; 148: 619-628.
12. Briscoe CP, Tadayyon M, Andrews JL, Benson WG, Chambers JK, Eilert MM et al. The orphan G protein-coupled receptor GPR40 is activated by medium and long chain fatty acids. J Biol Chem 2003; 278: 11303-11311.
13. Kotarsky K, Nilsson NE, Flodgren E, Owman C, Olde B. A human cell surface receptor activated by free fatty acids and thiazolidinedione drugs. Biochem Biophys Res Commun 2003; 301: 406-410.
14. Fukata M, Chen A, Vamadevan AS, Cohen J, Breglio K, Krishnareddy S et al. Toll-like receptor-4 promotes the development of colitis-Associated colorectal tumors. Gastroenterology 2007; 133: 1869-1881.
15. Wang D, Mann JR, DuBois RN. The role of prostaglandins and other eicosanoids in the gastrointestinal tract. Gastroenterology 2005; 128: 1445-1461.
16. Wang S, Liu Z, Wang L, Zhang X. NF-kappaB signaling pathway, inflammation and colorectal cancer. Cell Mol Immunol 2009; 6: 327-334.
17. Song L, Xiong H, Li J, Liao W, Wang L, Wu J et al. Sphingosine kinase-1 enhances resistance to apoptosis through activation of PI3K/Akt/NF-kappaB pathway in human non-small cell lung cancer. Clin Cancer Res 2011; 17: 1839-1849.
18. Cheng JC, Chou CH, Kuo ML, Hsieh CY. Radiation-enhanced hepatocellular carcinoma cell invasion with MMP-9 expression through PI3K/Akt/NF-kappaB signal transduction pathway. Oncogene 2006; 25: 7009-7018.
19. Kane LP, Shapiro VS, Stokoe D, Weiss A. Induction of NF-kappaB by the Akt/PKB kinase. Curr Biol 1999; 9: 601-604.
20. Hatanaka H, Tsukui M, Takada S, Kurashina K, Choi YL, Soda M et al. Identification of transforming activity of free fatty acid receptor 2 by retroviral expression screening. Cancer Sci 2010; 101: 54-59.
21. Sakurai T, Kudo M. Signaling pathways governing tumor angiogenesis. Oncology 2011; 81(Suppl 1): 24-29.
22. Wang Y, Alam GN, Ning Y, Visioli F, Dong Z, Nor JE et al. The unfolded protein response induces the angiogenic switch in human tumor cells through the PERK/ ATF4 pathway. Cancer Res 2012; 15: 5396-5406.
23. Yeung Y, Tebbutt NC. Bevacizumab in colorectal cancer: current and future directions. Expert Rev Anticancer Ther 2012; 12: 1263-1273.
24. Strickler JH, Hurwitz HI. Bevacizumab-based therapies in the first-line treatment of metastatic colorectal cancer. Oncologist 2012; 17: 513-524.
25. Koukourakis GV, Sotiropoulou-Lontou A. Targeted therapy with bevacizumab (Avastin) for metastatic colorectal cancer. Clin Transl Oncol 2011; 13: 710-714.
26. Romashkova JA, Makarov SS. NF-kappaB is a target of AKT in anti-Apoptotic PDGF signalling. Nature 1999; 401: 86-90.
27. Strieter RM. Masters of angiogenesis. Nat Med 2005; 11: 925-927.
28. Greten FR, Eckmann L, Greten TF, Park JM, Li ZW, Egan LJ et al. IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-Associated cancer. Cell 2004; 118: 285-296.
29. Kalluri R. EMT: when epithelial cells decide to become mesenchymal-like cells. J Clin Invest 2009; 119: 1417-1419.
30. Zheng HX, Cai YD, Wang YD, Cui XB, Xie TT, Li WJ et al. Fas signaling promotes motility and metastasis through epithelial-mesenchymal transition in gastrointestinal cancer. Oncogene 2013; 32: 1183-1192.
31. Williams K, Ghosh R, Vummidi Giridhar P, Gu G, Case T, Belcher SM et al. Inhibition of Stathmin1 Accelerates the Metastatic Process. Cancer Res 2012; 72: 5407-5417.
32. Wendt MK, Schiemann BJ, Parvani JG, Lee YH, Kang Y, Schiemann WP. TGF-beta stimulates Pyk2 expression as part of an epithelial-mesenchymal transition program required for metastatic outgrowth of breast cancer. Oncogene 2013; 32: 2005-2015.
33. Wu YY, Peck K, Chang YL, Pan SH, Cheng YF, Lin JC et al. SCUBE3 is an endogenous TGF-beta receptor ligand and regulates the epithelial-mesenchymal transition in lung cancer. Oncogene 2011; 30: 3682-3693.
34. Habbel P, Weylandt KH, Lichopoj K, Nowak J, Purschke M, Wang JD et al. Docosahexaenoic acid suppresses arachidonic acid-induced proliferation of LS-174T human colon carcinoma cells. World J Gastroenterol 2009; 15: 1079-1084.
35. Hossain Z, Hosokawa M, Takahashi K. Growth inhibition and induction of apoptosis of colon cancer cell lines by applying marine phospholipid. Nutr Cancer 2009; 61: 123-130.
36. Turk HF, Barhoumi R, Chapkin RS. Alteration of EGFR spatiotemporal dynamics suppresses signal transduction. PLoS One 2012; 7: e39682.
37. Im DS. Omega-3 fatty acids in anti-inflammation (pro-resolution) and GPCRs. Prog Lipid Res 2012; 51: 232-237.
38. Polozova A, Salem Jr N. Role of liver and plasma lipoproteins in selective transport of n-3 fatty acids to tissues: a comparative study of 14C-DHA and 3H-oleic acid tracers. J Mol Neurosci 2007; 33: 56-66.
39. Roodhart JM, Daenen LG, Stigter EC, Prins HJ, Gerrits J, Houthuijzen JM et al. senchymal stem cells induce resistance to chemotherapy through the release of platinum-induced fatty acids. Cancer Cell 2011; 20: 370-383.
40. Xu H, Wu Q, Dang S, Jin M, Xu J, Cheng Y et al. Alteration of CXCR7 expression mediated by TLR4 promotes tumor cell proliferation and migration in human colorectal carcinoma. PLoS One 2011; 6: e27399.
41. Zhao F, Zhang Y, Wang H, Jin M, He S, Shi Y et al. Blockade of osteopontin reduces alloreactive CD8 T cell-mediated graft-versus-host disease. Blood 2011; 117: 1723-1733.